Thomas DeLeon
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Co-authors
- Mitesh J. Borad (14 shared papers)Ahmad H. Ali (2 shared papers)Daniel H. Ahn (7 shared papers)Mohamad Bassam Sonbol (4 shared papers)Raquel T. Yokoda (4 shared papers)Alan H. Bryce (4 shared papers)Tanios Bekaii‐Saab (5 shared papers)Bashar Aqel (4 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)BMJ Supportive & Palliative Care (1 paper)npj Precision Oncology (1 paper)Future Oncology (1 paper)Hepatology (1 paper)
- Partner nations
- United StatesBrazilUnited Kingdom
In The Last Decade
Thomas DeLeon
20 papers receiving 552 citations
Peers
Comparison fields: 5 of 57
- Hepatology 166
- Oncology 195
- Transplantation 15
- Surgery 216
- Pulmonary and Respiratory Medicine 94
Countries citing papers authored by Thomas DeLeon
This map shows the geographic impact of Thomas DeLeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas DeLeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas DeLeon more than expected).
Fields of papers citing papers by Thomas DeLeon
This network shows the impact of papers produced by Thomas DeLeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas DeLeon. The network helps show where Thomas DeLeon may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas DeLeon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 128 | |
| 2 | 2018 | 121 | |
| 3 | 2017 | 93 | |
| 4 | 2017 | 39 | |
| 5 | 2019 | 38 | |
| 6 | 2020 | 24 | |
| 7 | 2018 | 23 | |
| 8 | 2021 | 23 | |
| 9 | 2018 | 17 | |
| 10 | 2018 | 13 | |
| 11 | 2017 | 9 | |
| 12 | Development and implementation of an instrument measuring CNCs' activities. | 1994 | 8 |
| 13 | Mycobacterium avium complex empyema in a patient with interferon gamma autoantibodies. | 2014 | 5 |
| 14 | 2017 | 5 | |
| 15 | 2018 | 5 | |
| 16 | 2018 | 3 | |
| 17 | 2017 | 2 | |
| 18 | 2018 | 2 | |
| 19 | 2018 | 1 | |
| 20 | 2017 | 1 |
About Thomas DeLeon
Thomas DeLeon is a scholar working on Oncology, Surgery, Hepatology, Molecular Biology and Epidemiology, having authored 20 papers that have together received 560 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (2 papers), Cutaneous Melanoma Detection and Management (2 papers), CAR-T cell therapy research (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hepatology (166 citations), Oncology (195 citations), Transplantation (15 citations), Surgery (216 citations) and Pulmonary and Respiratory Medicine (94 citations). Thomas DeLeon has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Mitesh J. Borad, Ahmad H. Ali, Daniel H. Ahn, Mohamad Bassam Sonbol, Raquel T. Yokoda, Alan H. Bryce, Tanios Bekaii‐Saab, Bashar Aqel, Marcela Salomao and Amit K. Mathur. Their work appears in journals such as Journal of Clinical Oncology, BMJ Supportive & Palliative Care, npj Precision Oncology, Future Oncology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.